Tag: Vaccines
Ad26.RSV.preF-RSV preF Protein Vaccine Immunogenic in Seniors
Vaccination results in lower RSV-mediated lower respiratory tract disease meeting one of three definitions
Moderna Will Offer Free COVID-19 Shots to Uninsured After PHE Ends
The U.S. public health emergency declaration is scheduled to end in May
Recommended 2023 Adult Immunization Schedule Published
Changes include new section relating to COVID-19 vaccines, addition of newly licensed vaccine for hepatitis B
U.S. to Test Vaccines in Poultry as Way to Curb Bird Flu Outbreak
Vaccines have been licensed in past outbreaks and poultry are already vaccinated for diseases like infectious bronchitis
Maternal COVID-19 Vaccination Highly Effective for Infants
Highly effective against delta, moderately effective against omicron infection and hospital admission in infants
Immunization Schedule for Children, Teens Updated for 2023
Changes to 2023 schedule include addition of new row for COVID-19, recommending vaccination for those aged 6 months to 18 years
Maternal Tdap Vaccination Protects Youngest Infants From Pertussis
Incidence of pertussis decreased among infants younger than 2 months after maternal Tdap vaccination implementation
COVID-19 Vaccine Protection Lasts at Least Six Months After Second Dose
Vaccine effectiveness against death was lower for patients aged 80 years and older
COVID-19 Vaccine Primary Series Coverage 76 Percent in Adults 60 Years and Older
Primary series coverage by end of 2022 was below the 100 percent target set for at-risk populations
mRNA COVID-19 Vaccines Not Tied to Increases in Guillain-Barré Syndrome
However, the Janssen COVID-19 vaccine was associated with increased risk at 21 and 42 days postvaccination
